<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nid</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология и диализ</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology and Dialysis</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1680-4422</issn><issn pub-type="epub">2618-9801</issn><publisher><publisher-name>Российское диализное общество</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">nid-1336</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Лучевая терапия как причина нарушения функции почек и артериальной гипертензии при опухолях урогенитальной локализации</article-title><trans-title-group xml:lang="en"><trans-title>Radiation therapy as a cause of renal functions` impairment and arterial hypertension in patients with urogenital malignancies</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Метелева</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Meteleva</surname><given-names>N. A.</given-names></name></name-alternatives><email xlink:type="simple">nmeteleva@yandex.ru Метелева Наталья Анатольевна</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козловская</surname><given-names>Н. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozlovskaya</surname><given-names>N. L.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Спесивцев</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Spesivtsev</surname><given-names>V. N.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глазкова</surname><given-names>Е. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Glazkova</surname><given-names>E. K.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Поликлиника ОАО «Газпром»</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>Кафедра нефрологии и гемодиализа ФППОВ ММА им. И.М. Сеченова, г. Москва</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>19</day><month>06</month><year>2025</year></pub-date><volume>10</volume><issue>3-4</issue><fpage>234</fpage><lpage>239</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Метелева Н.А., Козловская Н.Л., Спесивцев В.Н., Глазкова Е.К., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Метелева Н.А., Козловская Н.Л., Спесивцев В.Н., Глазкова Е.К.</copyright-holder><copyright-holder xml:lang="en">Meteleva N.A., Kozlovskaya N.L., Spesivtsev V.N., Glazkova E.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephro.ru/jour/article/view/1336">https://journal.nephro.ru/jour/article/view/1336</self-uri><abstract><p>Цель исследования - оценить состояние функции почек у больных опухолями урогенитальных локализаций, перенесших лучевую терапию (ЛТ) на область малого таза и регионарные лимфоузлы, для выявления больных хронической радиационной нефропатией (РН). Обследовано 18 пациентов: 8 женщин с диагнозом рак шейки или тела матки (возраст 54 ± 5,7 лет, суммарная доза облучения 55,6 ± 12,9 Гр) и 10 мужчин, с диагнозом рак предстательной железы (возраст 59,3 ± 6,1 лет, суммарная доза облучения 76,6 ± 22,4 Гр) после успешного комбинированного лечения (оперативное + ЛТ), не имевших ранее заболевания почек или тяжелой АГ. Исходное состояние функции почек оценивали по показателям креатинина сыворотки крови и СКФ (по формуле Кокрофта-Голта), в сроки от 2 до 4 мес. после завершения ЛТ. Оценка функции почек в позднем постлучевом периоде осуществлялась не ранее чем через 18 мес. после проведения ЛТ. Оценивали также динамику систолического и диастолического АД в соответствующие исследованию сроки. Результаты: В позднем постлучевом периоде у 50% пациентов выявлено ухудшение функции почек, проявляющееся выраженным снижением СКФ, у части больных с повышением уровня креатинина крови, и развитием АГ. У 22% больных отмечено нарушение фильтрационной функции почек, сочетающееся в ряде случаев с умеренным повышением АД. У 28% пациентов показатели функции почек и АД не отличались от исходных. Заключение: можно предполагать, что РН является частым поздним осложнением ЛТ и развивается у половины пациентов с опухолями урогенитальных локализаций, подвергшихся такому лечению. В связи с этим всем больным, перенесшим ЛТ на область малого таза и регионарные лимфоузлы, необходимо контролировать состояние функции почек и АД в динамике для своевременной диагностики хронической РН. Появление первых признаков снижения функции почек в раннем постлучевом периоде может свидетельствовать о развитии у пациентов острой РН с возможностью дальнейшей ее трансформации в хроническую.</p></abstract><trans-abstract xml:lang="en"><p>The aim of this study was to estimate the state of the renal functions in patients with urogenital tumors treated with irradiation in order to reveal patients with chronic radiation nephropathy. The retrospective analysis of 18 pts (8 F with diagnosis carcinoma of uterus or uterine cervix, mean age 54 ± 5,7 ys, total irradiation dose 55,6 ± 12,9 Gy and 10 M with diagnosis prostate cancer, mean age 59,3 ± 6,1 ys, total irradiation dose 76,6 ± 22,4 Gy) was undertaken. All patients were successfully treated with surgical intervention and irradiation in complex. Non patient have renal diseases or significant systemic hypertension before surgical and radiation treatment. The statement of renal functions was evaluated 2-4 months after irradiation (initial point) and 18 months after irradiation (late postirradiation period) by serum creatinine level and estimated glomerular filtration rate (Cockcroft-Gault formula). The dynamics of systolic and diastolic blood pressure was also monitored. The renal function impairment was observed in most patients in late postirradiation period: 50% pts had pronounced decline of glomerular filtration rate along with rising of serum creatinine level and development of moderate arterial hypertension in some of them; 22% pts had mild decline of glomerular filtration rate with slightly elevated blood pressure in some pts. In 28% of patients renal functions and blood pressure in late postirradiation period were similar to their initial levels. Chronic radiation nephropathy may be a common late complication after radiotherapy and may be found in half of patients with urogenital tumors. Such patients should be timely tested for the ascertainment of chronic radiation nephropathy. The first appearance of renal impairment symptoms in early postirradiation period may indicate acute radiation nephropathy with the possibility of subsequent chronic radiation nephropathy.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>радиационная нефропатия</kwd><kwd>лучевая терапия</kwd><kwd>нарушение функции почек</kwd><kwd>артериальная гипертензия</kwd><kwd>тромботическая микроангиопатия</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Важенин А.В., Фокин А.А. Избранные вопросы онкоангиологии. М.: Издательство РАМН 2006, 219 с.</mixed-citation><mixed-citation xml:lang="en">Важенин А.В., Фокин А.А. Избранные вопросы онкоангиологии. М.: Издательство РАМН 2006, 219 с.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Гранов А.М., Винокуров В.Л. Лучевая терапия в онкогинекологии и онкоурологии. СПб.: Фолиант 2002: 350 с.</mixed-citation><mixed-citation xml:lang="en">Гранов А.М., Винокуров В.Л. Лучевая терапия в онкогинекологии и онкоурологии. СПб.: Фолиант 2002: 350 с.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Гусева Н.Г. Системная склеродермия и псевдосклеродермические синдромы. М.: Медицина 1993: 272.</mixed-citation><mixed-citation xml:lang="en">Гусева Н.Г. Системная склеродермия и псевдосклеродермические синдромы. М.: Медицина 1993: 272.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Шилов Е.М., Козловская Н.Л., Метелева Н.А. и соавт. Клинические проявления нефропатии, связанной с антифосфолипидным синдромом, при первичном антифосфолипидном синдроме. Тер. арх. 2003; 6: 22-27.</mixed-citation><mixed-citation xml:lang="en">Шилов Е.М., Козловская Н.Л., Метелева Н.А. и соавт. Клинические проявления нефропатии, связанной с антифосфолипидным синдромом, при первичном антифосфолипидном синдроме. Тер. арх. 2003; 6: 22-27.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Cassady J.R. Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys 1995; 31: 1249-1256.</mixed-citation><mixed-citation xml:lang="en">Cassady J.R. Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys 1995; 31: 1249-1256.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chappell M.E., Keeling D.M., Prentice H.G., Sweny P. Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation. Bone Marrow Transplant 1988; 3: 339-347.</mixed-citation><mixed-citation xml:lang="en">Chappell M.E., Keeling D.M., Prentice H.G., Sweny P. Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation. Bone Marrow Transplant 1988; 3: 339-347.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Cogan M.G., Arieff A.I. Radiation nephritis and intravascular coagulation. Clin Nephrol. 1978 Aug; 10 (2): 74-8.</mixed-citation><mixed-citation xml:lang="en">Cogan M.G., Arieff A.I. Radiation nephritis and intravascular coagulation. Clin Nephrol. 1978 Aug; 10 (2): 74-8.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Cohen E.P. Radiation nephropathy after bone marrow transplantation. Kidney Int 2000; 58: 903-918.</mixed-citation><mixed-citation xml:lang="en">Cohen E.P. Radiation nephropathy after bone marrow transplantation. Kidney Int 2000; 58: 903-918.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cohen E.P., Robbins M.E.C. Radiation nephropathy. Semin Nephrol 2003; 23: 486-499.</mixed-citation><mixed-citation xml:lang="en">Cohen E.P., Robbins M.E.C. Radiation nephropathy. Semin Nephrol 2003; 23: 486-499.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Fisher E.R., Hellstorm H.R. Patogenesis of hypertension and pathologic changes in experimental renal irradiation. Lab Invest 1968; 19: 1530-1538.</mixed-citation><mixed-citation xml:lang="en">Fisher E.R., Hellstorm H.R. Patogenesis of hypertension and pathologic changes in experimental renal irradiation. Lab Invest 1968; 19: 1530-1538.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hartman F.W., Bolliger A., Doub H.P. Functional studies throughout the course of roentgen-ray nephritis in dogs. J Amer Med Ass 1927; 88: 139.</mixed-citation><mixed-citation xml:lang="en">Hartman F.W., Bolliger A., Doub H.P. Functional studies throughout the course of roentgen-ray nephritis in dogs. J Amer Med Ass 1927; 88: 139.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hulbert W.C., Ettinger U., Wood B.P. et al. Hyperreninemic hypertension secondary to radiation nephritis in a child. Urology 1985; 26: 153-156.</mixed-citation><mixed-citation xml:lang="en">Hulbert W.C., Ettinger U., Wood B.P. et al. Hyperreninemic hypertension secondary to radiation nephritis in a child. Urology 1985; 26: 153-156.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Jennette J.C., Ordóñez N.G. Radiation nephritis causing nephrotic syndrome. Urology. 1983 Dec; 22 (6): 631-634.</mixed-citation><mixed-citation xml:lang="en">Jennette J.C., Ordóñez N.G. Radiation nephritis causing nephrotic syndrome. Urology. 1983 Dec; 22 (6): 631-634.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kapur S., Chandra R., Antonovych T. Acute radiation nephritis. Light and electron microscopic observations. Arch Pathol Lab Med 1977 Sep; 101 (9): 469-473.</mixed-citation><mixed-citation xml:lang="en">Kapur S., Chandra R., Antonovych T. Acute radiation nephritis. Light and electron microscopic observations. Arch Pathol Lab Med 1977 Sep; 101 (9): 469-473.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Karim M.Y., Alba P., Tungekar M.F. et al. Hypertension as the presenting feature of the antiphospholipid syndrome. Lupus 2002; 11 (4): 253-256.</mixed-citation><mixed-citation xml:lang="en">Karim M.Y., Alba P., Tungekar M.F. et al. Hypertension as the presenting feature of the antiphospholipid syndrome. Lupus 2002; 11 (4): 253-256.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Luxton R.W. Radiation nephritis. Quart J Med 1953; 22: 215-219.</mixed-citation><mixed-citation xml:lang="en">Luxton R.W. Radiation nephritis. Quart J Med 1953; 22: 215-219.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Luxton R.W., Kunkler P.B. Radiation nephritis. Acta Radiol ETher (Stockh) 1964; 2: 169-178.</mixed-citation><mixed-citation xml:lang="en">Luxton R.W., Kunkler P.B. Radiation nephritis. Acta Radiol ETher (Stockh) 1964; 2: 169-178.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Madrazo A., Schwarz G., Churg J. Radiation nephritis: a review. J Urol 1975; 114: 822-827.</mixed-citation><mixed-citation xml:lang="en">Madrazo A., Schwarz G., Churg J. Radiation nephritis: a review. J Urol 1975; 114: 822-827.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Moll S., Pommer W., Mihatch M. et al. The lady who had a remote history of ovarian malignancy and developed thrombotic microangiopathy. NDT 2000; 15: 426-428.</mixed-citation><mixed-citation xml:lang="en">Moll S., Pommer W., Mihatch M. et al. The lady who had a remote history of ovarian malignancy and developed thrombotic microangiopathy. NDT 2000; 15: 426-428.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Page I.H. Production of nephritis in dogs by roentgen-rays. Amer J Med Sci 1936; 191: 251.</mixed-citation><mixed-citation xml:lang="en">Page I.H. Production of nephritis in dogs by roentgen-rays. Amer J Med Sci 1936; 191: 251.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Ruggenenti P., Noris M., Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 2001; 60: 831-846.</mixed-citation><mixed-citation xml:lang="en">Ruggenenti P., Noris M., Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 2001; 60: 831-846.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Wilson C., Ledingham J.M., Cohen M. Hypertension following X-irradiation of the kidneys. Lancet 1958; 1: 9.</mixed-citation><mixed-citation xml:lang="en">Wilson C., Ledingham J.M., Cohen M. Hypertension following X-irradiation of the kidneys. Lancet 1958; 1: 9.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
